Huaier vs capecitabine to prevent colon cancer return
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study compares two medicines to prevent colorectal cancer from coming back after surgery: a traditional Chinese medicine called Huaier and a standard chemotherapy pill called capecitabine. It is for people with stage 2 colon cancer that was completely removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have stage 2 colorectal cancer that was completely removed by surgery within the last 12 weeks.
- You did not receive chemo or radiation before surgery, and you haven’t had any cancer treatment after surgery yet.
- You are able to take oral medications (pills).
- You do not have low rectal cancer (within 12 cm from the anal edge) and no history of other cancers.
- You are not pregnant, breastfeeding, or planning pregnancy, and you are willing to follow up with the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether Huaier granules after surgery can lower the chance that colorectal cancer returns or spreads. It is for people who have recently had “radical” (complete) surgery for certain stages of colorectal cancer and are within about 2 months of that surgery.
This study tests whether a traditional Chinese medicine called Huaier Granule can help lower the chance that the cancer returns after surgery for colorectal cancer. It is for people whose CEA blood marker goes up again after surgery, even though scans show no cancer spread.
This trial tests two chemotherapy drugs, capecitabine alone or with oxaliplatin, in people aged 70 or older after surgery for stage III colorectal cancer. The goal is to find out which treatment works better to prevent cancer from coming back.
This trial tests a new drug (TQB2930) combined with chemotherapy, with or without another drug called bevacizumab, for people whose colorectal cancer has spread or cannot be removed by surgery and has a specific protein called HER2. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
This study tests whether adding a traditional Chinese medicine called Zhen-Qi-Jie-Du granules to usual palliative care can improve outcomes for people with advanced colorectal cancer. It aims to see if the combination offers extra benefits without causing more harm.
This trial tests whether adding Huaier granules, a traditional Chinese medicine, to a chemotherapy pill called capecitabine helps people with pancreatic cancer that cannot be removed by surgery. You would take the granules by mouth along with the chemo, and researchers will see if this combination helps control the cancer and improves well-being.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.